Cardlytics (CDLX) Issues Earnings Results

Share on StockTwits

Cardlytics (NASDAQ:CDLX) released its quarterly earnings data on Tuesday. The company reported ($0.15) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.63) by $0.48, Bloomberg Earnings reports. The company had revenue of $34.58 million for the quarter, compared to analyst estimates of $37.62 million. Cardlytics’s quarterly revenue was up 10.1% compared to the same quarter last year. Cardlytics updated its Q4 2018 guidance to EPS and its FY 2018 guidance to EPS.

NASDAQ:CDLX traded down $0.53 on Tuesday, reaching $17.75. The company’s stock had a trading volume of 140,548 shares, compared to its average volume of 168,480. Cardlytics has a 12-month low of $11.10 and a 12-month high of $28.29. The company has a quick ratio of 2.24, a current ratio of 2.24 and a debt-to-equity ratio of 1.29. The company has a market capitalization of $389.88 million and a P/E ratio of -2.21.

A number of research firms have weighed in on CDLX. Zacks Investment Research raised Cardlytics from a “sell” rating to a “hold” rating in a research note on Wednesday, September 19th. SunTrust Banks reissued a “buy” rating and set a $27.00 price objective on shares of Cardlytics in a research note on Tuesday, September 11th. KeyCorp lowered their price objective on Cardlytics from $30.00 to $28.00 and set an “overweight” rating on the stock in a research note on Wednesday, August 15th. Finally, Bank of America reissued a “hold” rating and set a $22.00 price objective on shares of Cardlytics in a research note on Friday, August 17th. Two investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus price target of $24.40.

In other Cardlytics news, Director Polaris Venture Management Co. sold 150,000 shares of Cardlytics stock in a transaction on Thursday, September 13th. The stock was sold at an average price of $25.04, for a total value of $3,756,000.00. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, COO Lynne Marie Laube sold 1,349 shares of Cardlytics stock in a transaction on Friday, August 17th. The shares were sold at an average price of $20.66, for a total value of $27,870.34. The disclosure for this sale can be found here. Insiders sold 155,194 shares of company stock worth $3,863,308 in the last 90 days.

A hedge fund recently raised its stake in Cardlytics stock. Bank of New York Mellon Corp raised its holdings in Cardlytics Inc (NASDAQ:CDLX) by 32.9% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 15,553 shares of the company’s stock after purchasing an additional 3,846 shares during the quarter. Bank of New York Mellon Corp owned 0.08% of Cardlytics worth $338,000 as of its most recent SEC filing. 53.48% of the stock is owned by institutional investors.

ILLEGAL ACTIVITY NOTICE: “Cardlytics (CDLX) Issues Earnings Results” was reported by Week Herald and is the sole property of of Week Herald. If you are viewing this piece on another domain, it was copied illegally and republished in violation of United States & international copyright & trademark law. The correct version of this piece can be accessed at

About Cardlytics

Cardlytics, Inc operates a purchase intelligence platform in the United States and the United Kingdom. It operates in two segments, Cardlytics Direct and Other Platform Solutions. The company's platform is the Cardlytics Direct solution, a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels.

See Also: Tariff

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with's FREE daily email newsletter.

Leave a Reply